- Home
- GILD vs TXN Comparison
GILD vs TXN Comparison
Compare GILD & TXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- TXN
- Stock Information
- Founded
- GILD 1987
- TXN 1930
- Country
- GILD United States
- TXN United States
- Employees
- GILD N/A
- TXN N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- TXN Semiconductors
- Sector
- GILD Health Care
- TXN Technology
- Exchange
- GILD Nasdaq
- TXN Nasdaq
- Market Cap
- GILD 129.9B
- TXN 137.4B
- IPO Year
- GILD 1992
- TXN N/A
- Fundamental
- Price
- GILD $110.08
- TXN $182.74
- Analyst Decision
- GILD Buy
- TXN Hold
- Analyst Count
- GILD 25
- TXN 26
- Target Price
- GILD $109.00
- TXN $192.50
- AVG Volume (30 Days)
- GILD 8.8M
- TXN 7.4M
- Earning Date
- GILD 04-24-2025
- TXN 07-22-2025
- Dividend Yield
- GILD 2.87%
- TXN 2.98%
- EPS Growth
- GILD 1118.07
- TXN N/A
- EPS
- GILD 4.73
- TXN 5.28
- Revenue
- GILD $28,735,000,000.00
- TXN $16,049,000,000.00
- Revenue This Year
- GILD $1.54
- TXN $11.94
- Revenue Next Year
- GILD $3.70
- TXN $10.22
- P/E Ratio
- GILD $23.27
- TXN $34.63
- Revenue Growth
- GILD 4.68
- TXN N/A
- 52 Week Low
- GILD $62.07
- TXN $139.95
- 52 Week High
- GILD $119.96
- TXN $220.39
- Technical
- Relative Strength Index (RSI)
- GILD 58.78
- TXN 56.94
- Support Level
- GILD $107.23
- TXN $173.75
- Resistance Level
- GILD $109.55
- TXN $186.48
- Average True Range (ATR)
- GILD 2.90
- TXN 4.00
- MACD
- GILD 1.01
- TXN -0.25
- Stochastic Oscillator
- GILD 90.02
- TXN 55.67
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About TXN Texas Instruments Incorporated
Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.